DK1931705T3 - Fremgangsmåde til amidering af polypeptider med c-terminale basiske aminosyrer under anvendelse af specifikke endoproteaser - Google Patents

Fremgangsmåde til amidering af polypeptider med c-terminale basiske aminosyrer under anvendelse af specifikke endoproteaser

Info

Publication number: DK1931705T3
Authority: DK; Denmark
Prior art keywords: amidation; polypeptides; amino acids; basic amino; terminal basic
Prior art date: 2005-09-27

Application number

DK06792022.3T

Other languages

English (en)

Inventor

Sebastian Rissom

Paul Habermann

Christophe Salagnad

Frank Zocher

Laure Landric-Burtain

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-27

Filing date

2006-09-13

Publication date

2012-01-09

2006-09-13 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2012-01-09 Application granted granted Critical

2012-01-09 Publication of DK1931705T3 publication Critical patent/DK1931705T3/da

Links

101710118538 Protease Proteins 0.000 title 1
230000009435 amidation Effects 0.000 title 1
238000007112 amidation reaction Methods 0.000 title 1
150000001413 amino acids Chemical class 0.000 title 1
210000004899 c-terminal region Anatomy 0.000 title 1
238000000034 method Methods 0.000 title 1
229920001184 polypeptide Polymers 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Analytical Chemistry (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK06792022.3T 2005-09-27 2006-09-13 Fremgangsmåde til amidering af polypeptider med c-terminale basiske aminosyrer under anvendelse af specifikke endoproteaser DK1931705T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102005046113A DE102005046113A1 (de)	2005-09-27	2005-09-27	Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen
PCT/EP2006/008903 WO2007036299A2 (de)	2005-09-27	2006-09-13	Verfahren zur amidierung von polypeptiden mit c-terminalen basischen aminosäuren unter verwendung spezifischer endoproteasen

Publications (1)

Publication Number	Publication Date
DK1931705T3 true DK1931705T3 (da)	2012-01-09

Family

ID=37735179

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06792022.3T DK1931705T3 (da)	2005-09-27	2006-09-13	Fremgangsmåde til amidering af polypeptider med c-terminale basiske aminosyrer under anvendelse af specifikke endoproteaser

Country Status (20)

Country	Link
US (1)	US8765910B2 (da)
EP (1)	EP1931705B1 (da)
JP (1)	JP5352234B2 (da)
KR (1)	KR101363299B1 (da)
CN (1)	CN101268097A (da)
AR (1)	AR055179A1 (da)
AT (1)	ATE523522T1 (da)
AU (1)	AU2006296818B2 (da)
BR (1)	BRPI0616712B8 (da)
CA (1)	CA2623547C (da)
CY (1)	CY1112182T1 (da)
DE (1)	DE102005046113A1 (da)
DK (1)	DK1931705T3 (da)
ES (1)	ES2373237T3 (da)
IL (1)	IL190229A (da)
MY (1)	MY148447A (da)
PL (1)	PL1931705T3 (da)
PT (1)	PT1931705E (da)
SI (1)	SI1931705T1 (da)
WO (1)	WO2007036299A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006031955A1 (de) *	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de)	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Amidiertes Insulin Glargin
RS59913B1 (sr)	2008-10-17	2020-03-31	Sanofi Aventis Deutschland	Kombinacija insulina i glp-1-agonista
CN102596175A (zh)	2009-07-06	2012-07-18	赛诺菲-安万特德国有限公司	含有甲硫氨酸的水性胰岛素制备物
MY180661A (en)	2009-11-13	2020-12-04	Sanofi Aventis Deutschland	Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
PT3345593T (pt)	2009-11-13	2023-11-27	Sanofi Aventis Deutschland	Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
CA2786340C (en)	2010-02-11	2017-08-22	F. Hoffmann-La Roche Ag	Igf-i poly (ethylene glycol) conjugates
PL2611458T3 (pl)	2010-08-30	2017-02-28	Sanofi-Aventis Deutschland Gmbh	Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es)	2011-08-29	2014-04-09	Sanofi Aventis Deutschland	Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI780236B (zh)	2013-02-04	2022-10-11	法商賽諾菲公司	胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
MX2016008979A (es)	2014-01-09	2016-10-04	Sanofi Sa	Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina.
MX2016008978A (es)	2014-01-09	2016-10-04	Sanofi Sa	Formulaciones farmaceuticas de analogos de insulina y/o derivados de insulina estabilizadas y que estan libres de glicerol.
BR112016015851A2 (pt)	2014-01-09	2017-08-08	Sanofi Sa	Formulações farmacêuticas estabilizadas de insulina aspart
EP3229828B1 (en)	2014-12-12	2023-04-05	Sanofi-Aventis Deutschland GmbH	Insulin glargine/lixisenatide fixed ratio formulation
WO2016135041A1 (en)	2015-02-26	2016-09-01	INSERM (Institut National de la Santé et de la Recherche Médicale)	Fusion proteins and antibodies comprising thereof for promoting apoptosis
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
CN108226362B (zh) *	2016-12-21	2021-05-25	鲁南制药集团股份有限公司	一种聚乙二醇化促胰岛素分泌肽类似物中间体的分析检测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5332664A (en) *	1981-07-15	1994-07-26	Celltech Limited	Human calcitonin precursor polyprotein structural gene
US5416073A (en) *	1983-08-10	1995-05-16	The Adminstrators Of The Tulane Educational Fund	Growth hormone-releasing peptides and method of treating animals, therewith
US5496924A (en) *	1985-11-27	1996-03-05	Hoechst Aktiengesellschaft	Fusion protein comprising an interleukin-2 fragment ballast portion
DK220890D0 (da) *	1990-09-14	1990-09-14	Ole Buchardt	Fremgangsmaade til fremstilling af c-terminalt amiderede peptider
EP0490249B1 (en) *	1990-12-10	1995-03-15	F. Hoffmann-La Roche Ag	Process for the enzymatic preparation of GRF(1-44)NH2
JPH07509128A (ja) *	1992-07-13	1995-10-12	バイオネブラスカ・インコーポレーテッド	組換型ポリペプチドの修飾方法
DE19944870A1 (de) *	1999-09-18	2001-03-29	Aventis Pharma Gmbh	Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
US7638618B2 (en) *	2001-02-20	2009-12-29	Sanofi-Aventis Deutschland Gmbh	Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
BR0314996A (pt)	2002-10-02	2005-08-09	Zealand Pharma As	Composição, composição farmaceuticamente aceitável, método para produzir a composição, métodos para estabilizar a exendina-4 (1-39) ou uma sua variante, derivado ou análogo contra a degradação, antes, durante ou após o uso pretendido, para tratar doenças, para tratar de estados de doenças associados com nìveis elevados de glicose do sangue, para a regulação dos nìveis de glicose do sangue, para a regulação do esvaziamento gástrico, para estimular a liberação de insulina em um mamìfero para reduzir o nìvel de glicose do sangue em um mamìfero, para reduzir o nìvel de lipìdeos plasmáticos em um mamìfero, para reduzir a mortalidade e a morbidez após o infarto miocárdico em um mamìfero, para estimular a liberação de insulina em um mamìfero, e para produzir uma exendina (1-39) estabilizada, e, exendina (1-39) estabilizada
ES2309785T3 (es)	2004-08-13	2008-12-16	F. Hoffmann-La Roche Ag	Modificacion c-terminal de polipeptidos.
DE102004058306A1 (de) *	2004-12-01	2006-07-27	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden
DE102006031955A1 (de) *	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) *	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Amidiertes Insulin Glargin
JP5695909B2 (ja) *	2008-01-09	2015-04-08	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
MY152979A (en) *	2008-01-09	2014-12-15	Sanofi Aventis Deutschland	Novel insulin derivatives having an extremely delayed time-action profile

2005
- 2005-09-27 DE DE102005046113A patent/DE102005046113A1/de not_active Withdrawn
2006
- 2006-09-13 KR KR1020087007470A patent/KR101363299B1/ko not_active Expired - Fee Related
- 2006-09-13 ES ES06792022T patent/ES2373237T3/es active Active
- 2006-09-13 BR BRPI0616712A patent/BRPI0616712B8/pt not_active IP Right Cessation
- 2006-09-13 US US12/065,643 patent/US8765910B2/en active Active
- 2006-09-13 AT AT06792022T patent/ATE523522T1/de active
- 2006-09-13 PT PT06792022T patent/PT1931705E/pt unknown
- 2006-09-13 JP JP2008532625A patent/JP5352234B2/ja not_active Expired - Fee Related
- 2006-09-13 CA CA2623547A patent/CA2623547C/en not_active Expired - Fee Related
- 2006-09-13 MY MYPI20080633A patent/MY148447A/en unknown
- 2006-09-13 AU AU2006296818A patent/AU2006296818B2/en not_active Ceased
- 2006-09-13 DK DK06792022.3T patent/DK1931705T3/da active
- 2006-09-13 SI SI200631178T patent/SI1931705T1/sl unknown
- 2006-09-13 EP EP06792022A patent/EP1931705B1/de not_active Not-in-force
- 2006-09-13 CN CNA2006800340261A patent/CN101268097A/zh active Pending
- 2006-09-13 WO PCT/EP2006/008903 patent/WO2007036299A2/de not_active Ceased
- 2006-09-13 PL PL06792022T patent/PL1931705T3/pl unknown
- 2006-09-25 AR ARP060104168A patent/AR055179A1/es active IP Right Grant
2008
- 2008-03-17 IL IL190229A patent/IL190229A/en active IP Right Grant
2011
- 2011-12-06 CY CY20111101215T patent/CY1112182T1/el unknown

Also Published As

Publication number	Publication date
JP5352234B2 (ja)	2013-11-27
CA2623547A1 (en)	2007-04-05
KR20080061367A (ko)	2008-07-02
KR101363299B1 (ko)	2014-02-21
SI1931705T1 (sl)	2011-12-30
BRPI0616712B1 (pt)	2018-10-16
IL190229A (en)	2012-12-31
AU2006296818B2 (en)	2012-03-01
WO2007036299A2 (de)	2007-04-05
EP1931705B1 (de)	2011-09-07
PL1931705T3 (pl)	2012-02-29
BRPI0616712A2 (pt)	2011-06-28
ATE523522T1 (de)	2011-09-15
US20100311112A1 (en)	2010-12-09
CA2623547C (en)	2015-08-11
DE102005046113A1 (de)	2007-03-29
MY148447A (en)	2013-04-30
IL190229A0 (en)	2011-08-01
WO2007036299A3 (de)	2007-05-31
JP2009509515A (ja)	2009-03-12
AR055179A1 (es)	2007-08-08
EP1931705A2 (de)	2008-06-18
BRPI0616712B8 (pt)	2021-05-25
CY1112182T1 (el)	2015-12-09
PT1931705E (pt)	2011-12-05
CN101268097A (zh)	2008-09-17
AU2006296818A1 (en)	2007-04-05
ES2373237T3 (es)	2012-02-01
US8765910B2 (en)	2014-07-01

Publication	Publication Date	Title
DK1931705T3 (da)	2012-01-09	Fremgangsmåde til amidering af polypeptider med c-terminale basiske aminosyrer under anvendelse af specifikke endoproteaser
DK1973429T3 (da)	2013-10-28	Proteinhydrolysater og fremgangsmåde til fremstilling
DK2035554T3 (da)	2013-06-17	Celle-fri syntese af proteiner indeholdende ikke-naturlige aminosyrer
DK2046819T3 (da)	2015-06-22	Fremgangsmåder til forøgelse af secernering af polypeptider med biologisk aktivitet
BRPI0907363A2 (pt)	2015-08-18	Métodos e composições relativos a peptídeos e proteínas com elementos de c-terminal
DK2061897T3 (da)	2020-06-02	Fed-batch-fermenteringsproces med høj celledensitet til fremstilling af rekombinant protein
PT2339014E (pt)	2015-10-13	Métodos e composições compreendendo aminoácidos não-naturais
DK2061803T4 (da)	2022-12-05	Fremgangsmåde til oprensning af fc-holdige proteiner
DK1984517T3 (da)	2012-11-26	Fremgangsmåde til modulering af rekombinante proteiners mannoseindhold
DK1877090T3 (da)	2014-04-14	Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
EP2242505A4 (en)	2012-03-07	GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
DK2390265T3 (da)	2014-02-10	Insulinotropisk peptidderivat med modificeret N-terminal aminosyre
EP2098859A4 (en)	2010-04-28	METHOD FOR QUANTIFICATION OF PEPTIDE AND PROTEIN
IL209386A0 (en)	2011-01-31	Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
DK1983849T3 (da)	2013-07-08	Fødevaresammensætning omfattende aminosyrer
DK3136030T3 (da)	2019-10-14	Fremgangsmåde til lyofilisering
NO20054958D0 (no)	2005-10-25	Substitulerte aminokarboksylsyrer
DK3202779T3 (da)	2020-03-09	Hgh polypeptider med langtidsvirkning og anvendelser deraf
BRPI0819092A2 (pt)	2014-10-14	Evolução direcionada usando proteínas que compreendem aminoácidos não naturais.
DK2081669T3 (da)	2019-01-02	Fremgangsmåde og anordning til fremstilling af granulater
DK1999259T3 (da)	2014-10-06	Sekvensspecifik inkorporering af aminosyrer i molekyler
EP2030015A4 (en)	2009-11-11	REALIZATION OF PROTEIN SURFACES
DK1941026T3 (da)	2014-07-21	Fremgangsmåder til fremstilling af protein under anvendelse af anti-senescensforbindelser
IL190483A0 (en)	2008-11-03	Methods for use of branched chain amino acids
DE602005012555D1 (de)	2009-03-12	Künstliches protein zur absoluten quantifizierung von proteinen und verwendungen davon